Vigilant Biosciences Announces Commencement of FDA Studies for OncAlert® Cancer Test
Vigilant Biosciences Announces Commencement of FDA Studies for OncAlert® Cancer Test FORT LAUDERDALE, Fla., May 10, 2017 PRNewswire Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection…